¶ androgen receptor
A nuclear receptor protein (NR3C4) that functions as a ligand-activated transcription factor, mediating the biological effects of androgens (Testosterone and dihydrotestosterone) by regulating expression of hundreds of target genes. Present in virtually all tissues with particularly high expression in reproductive organs, skeletal muscle, bone, brain, and skin, the androgen receptor orchestrates sexual differentiation, maintains muscle mass and bone density, modulates cognition and mood, and influences immune function through both genomic and rapid non-genomic signaling pathways.
Think of the androgen receptor as a master architect who only works when holding the right blueprint—either Testosterone or its more potent cousin dihydrotestosterone (DHT). The architect normally sits idle in the cytoplasm (the building's waiting room), but when Testosterone arrives and binds to the receptor, this triggers a transformation. The architect-blueprint complex moves into the nucleus (the executive office), where it finds specific construction sites on DNA called androgen response elements (AREs). At these sites, the receptor doesn't build directly—instead, it recruits teams of construction workers (coactivator proteins) who start transcribing genetic instructions into messenger RNA, eventually building new proteins. In the Hypothalamus, this construction project during fetal development builds the male-typical INAH-3 nucleus—bigger and with more neurons. Without functional androgen receptors, as in complete androgen insensitivity syndrome, the architect never shows up for work: an XY individual develops a female-typical brain structure despite having testes producing Testosterone. The hormone is there, but without the receptor-architect to read the blueprint and direct construction, the default female developmental program proceeds. The same architect works in adult muscle cells, directing the construction of contractile proteins; in bone, orchestrating mineralization; and in neurons, maintaining survival pathways and synaptic plasticity.
The androgen receptor signaling cascade involves both classical genomic and rapid non-genomic pathways:
Classical Genomic Pathway:
- Testosterone or DHT (produced via 5α-reductase conversion of Testosterone) diffuses through cell membrane
- Ligand binds to androgen receptor in cytoplasm, causing dissociation of heat shock proteins (HSP90, HSP70) that stabilize the unbound receptor
- Hormone-receptor complex undergoes conformational change, exposing nuclear localization sequence
- Complex dimerizes and translocates to nucleus
- Receptor dimer binds to androgen response elements (AREs) in promoter regions of target genes—consensus sequence: 5'-GGTACAnnnTGTTCT-3'
- Recruitment of coactivator complexes (p160 family, CBP/p300) and chromatin remodeling proteins
- RNA polymerase II transcription of target genes including: AR itself (autoregulation), PSA (prostate cancer marker), IGF-1, BDNF, myosin heavy chain genes, osteocalcin, EPO, and hundreds more
- Downstream effects on protein synthesis, cell division, differentiation, and survival
Non-Genomic Rapid Signaling:
- Membrane-associated androgen receptors activate AKT pathway, ERK1-2, and PKC within minutes
- Calcium influx via modulation of voltage-gated channels
- CREB phosphorylation independent of nuclear translocation
- Rapid modulation of neurotransmitter release and synaptic plasticity
Brain-Specific Sexual Differentiation:
- During Critical Period (prenatal in humans, early postnatal in rodents), androgens organize neural circuitry
- In INAH-3 and SDN-POA: androgen receptor activation → increased BDNF expression → enhanced neuronal survival and dendritic arborization → 2-3x larger nucleus in males
- Aromatization of Testosterone to Oestradiol via aromatase also contributes (combined androgen + estrogen receptor signaling)
- Without androgen receptor function (CAIS), female-typical organization occurs regardless of Testosterone levels
graph TD
T[Testosterone/DHT] -->|binds| AR[Androgen Receptor cytoplasmic]
AR -->|HSP dissociation| Conf[Conformational change]
Conf -->|dimerization| Dim[AR-AR dimer]
Dim -->|nuclear translocation| Nuc[Nuclear entry]
Nuc -->|binds ARE| DNA[Androgen Response Elements]
DNA -->|recruits| CoAct[Coactivator complexes]
CoAct -->|activates| RNA[RNA Pol II transcription]
RNA -->|produces| mRNA1["Muscle genes: myosin MHC"]
RNA -->|produces| mRNA2["Brain genes: BDNF IGF-1"]
RNA -->|produces| mRNA3["Bone genes: osteocalcin"]
RNA -->|produces| mRNA4["Metabolic genes: AR EPO"]
T -.->|membrane AR| Rapid[Non-genomic signaling]
Rapid -->|activates| ERK[ERK/AKT/PKC]
Rapid -->|influx| Ca["Ca²⁺ channels"]
ERK -->|phosphorylates| CREB
AR -->|polymorphisms| CAG[CAG repeat length]
CAG -->|">24 repeats"| Reduced[Reduced receptor sensitivity]
Reduced -.->|risk| Disease[Prostate cancer, infertility, metabolic syndrome]
Androgen receptor function is central to understanding multiple cPNI presentations across the lifespan. In the context of the Metamodel framework, androgen signaling exemplifies how evolutionary adaptations (sexual differentiation for reproductive success) create vulnerabilities in modern environments (age-related decline, endocrine disruptors). The selfish brain prioritizes androgen signaling to maintain cognitive function—declining Testosterone and receptor sensitivity after age 40 contributes to cognitive decline, particularly in spatial memory and executive function mediated by Hippocampus and Prefrontal cortex.
Sexual Development and Gender Identity:
Complete androgen insensitivity syndrome (CAIS) patients—genetically XY with non-functional androgen receptors—develop female external genitalia, female gender identity, and female-typical brain structures including smaller INAH-3 despite normal Testosterone production. This natural experiment demonstrates that androgen receptor activation, not chromosomes, determines brain sexual differentiation. Partial androgen insensitivity creates phenotypic variability and may relate to gender dysphoria in some cases.
Cognitive and Mood Effects:
Testosterone via androgen receptor maintains:
Musculoskeletal System:
Androgen receptor activation is required for:
Metabolic Integration:
Immune Modulation:
Intervention Implications:
Address androgen receptor signaling through:
Polymorphisms:
CAG repeat length in AR gene exon 1 affects receptor sensitivity:
- Nuclear receptor (NR3C4 gene on X chromosome) activated by Testosterone (Kd ≈1 nM) and DHT (Kd ≈0.3 nM—3x higher affinity)
- DHT produced from Testosterone via 5α-reductase is more potent because it dissociates slower from receptor
- Brain expression highest in Hypothalamus (especially SDN-POA/INAH-3), Amygdala, Hippocampus, and Cerebral Lateralization centers
- CAIS patients (XY, non-functional AR) develop female-typical brain despite normal Testosterone levels—definitive proof of androgen receptor role in sexual differentiation
- Male INAH-3 volume 2.5x larger than female due to androgen receptor-mediated neuronal survival during development
- Testosterone peaks at age 20-30 (700-1000 ng/dL), declines 1-2% annually after 30
- Free Testosterone <50 pg/mL associated with 2x increased Depression risk in men
- Receptor half-life ≈3-4 hours; requires continuous ligand binding for sustained effects
- Polymorphic CAG repeat region (normal 9-36 repeats) inversely correlates with receptor activity
- Androgen receptor regulates >500 genes including muscle contractile proteins, BDNF, EPO, bone matrix proteins, and its own expression (positive feedback)
- Exercise-induced myokine secretion (Irisin, IL-6) partly mediated through androgen receptor in skeletal muscle
- Receptor degradation accelerated by ubiquitination; stabilized by Heat shock proteins in unbound state
- Non-genomic membrane signaling occurs within 1-5 minutes via ERK, AKT pathway, and PKC activation
- Insulin resistance and visceral adiposity both cause and result from low androgen receptor signaling (bidirectional relationship)
- Testosterone — primary endogenous ligand; circulating levels determine receptor activation but tissue sensitivity varies
- dihydrotestosterone — more potent androgen receptor agonist formed via 5α-reductase; responsible for prostate growth and male pattern baldness
- 5α-reductase — enzyme converting Testosterone to DHT in target tissues including brain, prostate cancer, and skin
- INAH-3 — sexually dimorphic nucleus in human Hypothalamus whose size depends on androgen receptor activation during Critical Period
- SDN-POA — rodent sexually dimorphic nucleus of preoptic area, equivalent to INAH-3, demonstrating androgen effects on brain organization
- aromatase — converts Testosterone to Oestradiol; brain sexual differentiation requires both androgen and estrogen receptor signaling
- Oestradiol — Testosterone metabolite activating estrogen receptors; combined signaling necessary for male brain differentiation
- estrogen receptors — work synergistically with androgen receptor in brain development and bone metabolism
- BDNF — brain-derived neurotrophic factor upregulated by androgen receptor in Hippocampus and Amygdala, supporting neuroplasticity
- Hippocampus — high androgen receptor expression; Testosterone maintains volume and Adult Hippocampal Neurogenesis
- Amygdala — androgen receptor modulates emotional processing and threat sensitivity; dimorphic activation in males vs females
- Prefrontal cortex — androgen signaling maintains executive function and working memory; decline contributes to cognitive impairment
- Muscle hypertrophy — androgen receptor activation required for maximal muscle protein synthesis via mTORC1 and myofibrillar protein transcription
- muscle protein synthesis — directly upregulated by androgen receptor-mediated transcription of myosin heavy chain and actin genes
- mTORC1 — activated by androgen receptor via AKT pathway, driving protein synthesis and muscle growth
- skeletal muscle — expresses androgen receptor constitutively; Testosterone increases receptor number creating positive feedback
- Satellite cells — muscle stem cells activated by androgen receptor for repair and hypertrophy
- Osteoblasts — bone-forming cells requiring androgen receptor signaling for matrix protein synthesis and mineralization
- bone density — maintained by androgen receptor-mediated osteoblast activity; hypogonadism causes osteoporosis
- Osteocalcin — bone hormone and androgen receptor target gene; creates feedback loop between bone and Testosterone production
- sarcopenia — age-related muscle loss accelerated by declining androgen receptor signaling after age 40
- Cortisol — chronically elevated Cortisol from chronic stress suppresses Testosterone production and competes for Glucocorticoid Receptor
- Insulin resistance — bidirectional with low androgens; androgen receptor maintains GLUT4 expression in muscle
- visceral adiposity — increased with low Testosterone; visceral fat aromatizes Testosterone to Oestradiol worsening deficiency
- metabolic syndrome — associated with low Testosterone and reduced androgen receptor sensitivity (CAG repeat polymorphisms)
- Leptin — androgen receptor modulates Leptin sensitivity in Hypothalamus; low androgens → Leptin resistance
- prostate cancer — initially androgen-dependent; androgen receptor drives proliferation in early disease, leading to androgen deprivation therapy
- hypogonadism — total Testosterone <300 ng/dL or free Testosterone <50 pg/mL; causes cognitive decline, mood disorders, sarcopenia, osteoporosis
- Depression — low Testosterone and reduced androgen receptor function associated with 2-3x increased risk, especially in older men
- Anxiety — androgen receptor modulates GABA signaling in Amygdala; low androgens increase anxiety sensitivity
- cognitive decline — accelerated by age-related androgen decline; Testosterone replacement may slow Alzheimer's Disease progression in some cases
- Alzheimer's Disease — lower Testosterone levels correlate with earlier onset and faster progression; androgen receptor maintains BDNF and synaptic density
- gender dysphoria — partial androgen insensitivity or timing variations in androgen receptor activation may contribute in some cases
- libido — directly regulated by androgen receptor in Hypothalamus and limbic regions
- Dopamine Release — androgen receptor upregulates dopamine receptor expression in Nucleus accumbens and Ventral tegmental area
- IGF-1 — insulin-like growth factor transcriptionally upregulated by androgen receptor; mediates anabolic effects
- EPO — erythropoietin transcription stimulated by androgen receptor; explains higher hemoglobin in males
- IL-6 — androgen receptor inhibits IL-6 transcription in macrophages, contributing to sex differences in inflammatory responses
- NLRP3 inflammasome — suppressed by Testosterone via androgen receptor; low androgens → increased inflammasome activation
- Th1 — androgen receptor activation shifts balance toward Th2, explaining female predominance in Autoimmunity
- Exercise — resistance training upregulates androgen receptor expression and Testosterone production; creates positive feedback loop
- Resistance training — maximally effective stimulus for androgen receptor upregulation and ligand production
- Sleep — Testosterone production peaks during REM sleep; sleep deprivation reduces androgen levels 10-15%
- Zinc — required cofactor for Testosterone synthesis and androgen receptor function; deficiency impairs both
- Vitamin D — VDR and androgen receptor share coactivators; Vitamin D deficiency reduces Testosterone production
- AKT pathway — activated by androgen receptor in non-genomic signaling; drives protein synthesis and cell survival
- ERK1-2 — rapidly activated by membrane androgen receptor, modulating gene transcription independently of nuclear translocation
- CREB — phosphorylated by androgen receptor-activated kinases, regulating BDNF and other neuroplasticity genes
- Module 1 — Sexual differentiation of brain, INAH-3 development
- Module 5 — Neuroendocrine integration, stress effects on androgen axis